TCR2 Therapeutics (TCRR) Earnings Per Share (EPS)

Price: $1.48
Market Cap: $58.11M
Avg Volume: 325.04K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.93322
52W Range: $0.821-3.88
Website: TCR2 Therapeutics
Earnings Per Share (EPS) Summary (Annual)

According to TCR2 Therapeutics's latest annual financial reports, the company has an earnings per share (EPS) of $-3.93 and a diluted EPS of $-3.93. The EPS indicates the portion of a company's profit allocated to each outstanding share of common stock, serving as an indicator of a company's profitability.

The company's EPS growth rate stands at -49.43%, and the diluted EPS growth rate is -49.43%. These metrics reflect the annual growth rate of earnings per share and diluted earnings per share over the specified period.

EPS

$-3.93

Diluted EPS

$-3.93

EPS Growth

-49.43%

TCR2 Therapeutics Historical EPS
$-1.00$-1.00$-2.00$-2.00$-3.00$-3.00$-4.00$-4.00EPS201720172018201820192019202020202021202120222022
TCR2 Therapeutics Historical EPS Growth
75.30%75.30%11.79%11.79%-51.73%-51.73%-115.24%-115.24%EPS Growth201720172018201820192019202020202021202120222022
EPS History

The table below shows the EPS for each year, with the latest data available for the last fiscal year 2022.

Year EPS Change
2022 $-3.93 -49.43%
2021 $-2.63 -9.58%
2020 $-2.4 -6.19%
2019 $-2.26 -115.24%
2018 $-1.05 58.82%
2017 $-2.55 -32.12%
2016 $-1.93 0.00%

Related Metrics

Explore detailed financial metrics and analysis for TCRR.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio